newsfilter
← Latest News
GlobeNewswire·

Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services

SEATTLE, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS, "Atossa" or the "Company")), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and